These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 998482)

  • 1. An approach to the treatment of essential hypertension.
    Vlachakis ND; Mendlowitz M
    Am Heart J; 1976 Dec; 92(6):750-7. PubMed ID: 998482
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Alpha- and beta-adrenergic receptor blocking agents combined with a diuretic in the treatment of essential hypertension.
    Vlachakis ND; Mendlowitz M
    J Clin Pharmacol; 1976 Jul; 16(7):352-60. PubMed ID: 7576
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Blood pressure responses to catecholamines during beta-adrenergic blockade with propranolol in hypertensive subjects.
    Vlachakis ND; DeGuia D; Mendlowitz M
    Chest; 1977 Jan; 71(1):38-43. PubMed ID: 830497
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of nifedipine and propranolol on blood flow, venous compliance and blood pressure in essential hypertension.
    Ogilvie RI
    Can Med Assoc J; 1985 May; 132(10):1137-41. PubMed ID: 3995432
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Minoxidil in treatment resistant hypertension].
    Tenschert W; Vetter W; Studer A; Reuteler H; Furrer J; Nussberger J; Siegenthaler W
    Schweiz Med Wochenschr; 1979 Dec; 109(47):1869-73. PubMed ID: 531565
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Controlled comparison of labetalol and propranolol in the management of severe hypertension.
    Pugsley DJ; Armstrong BK; Nassim MA; Beilin LJ
    Br J Clin Pharmacol; 1976 Aug; 3(4 Suppl 3):777-82. PubMed ID: 791331
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Crossover comparison of nitrendipine with propranolol in patients with essential hypertension.
    Fritschka E; Distler A; Gotzen R; Thiede HM; Philipp T
    J Cardiovasc Pharmacol; 1984; 6 Suppl 7():S1100-4. PubMed ID: 6085375
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Paroxysmal neurogenic hypertension and its prevention in patients with cervical spinal cord lesions.
    Sommers DK
    S Afr Med J; 1979 Jul; 56(1):14-8. PubMed ID: 483097
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Different antihypertensive effect of beta-blocking drugs in low and normal-high renin hypertension.
    Kralberg BE; Tolagen K
    Am J Med; 1976 May; 60(6):891-6. PubMed ID: 14504
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Triamterene in the treatment of hypertension with hydrochlorothiazide and propranolol (author's transl)].
    Düsing R; Kramer HJ
    Dtsch Med Wochenschr; 1977 Oct; 102(43):1541-6. PubMed ID: 913294
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A comparative trial of clonidine, propranolol and placebo in the treatment of moderate hypertension.
    Wilkinson PR; Raftery EB
    Br J Clin Pharmacol; 1977 Jun; 4(3):289-94. PubMed ID: 332218
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of propranolol on cyclic AMP excretion and plasma renin activity in labile essentrial hypertension.
    Hamet P; Kuchel O; Cuche JL; Boucher R; Genest J
    Can Med Assoc J; 1973 Dec; 109(11):1099-103. PubMed ID: 4357222
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ketanserin versus propranolol in the treatment of mild and moderate essential hypertension: corroboration with ambulatory blood pressure monitoring.
    Novo S; Alaimo G; Giordano U; Raineri A; Strano A
    J Cardiovasc Pharmacol; 1987; 10 Suppl 3():S104-6. PubMed ID: 2446055
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Unexpected pressor responses to propranolol in essential hypertension. An interaction between renin, aldosterone and sympathetic activity.
    Drayer JI; Keim HJ; Weber MA; Case DB; Laragh JH
    Am J Med; 1976 May; 60(6):897-903. PubMed ID: 190882
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Methyldopa and propranolol or practolol in moderate hypertension.
    Petrie JC; Galloway DB; Jeffers TA; Millar HR; Smith MC; Wood RA; Lewis JA; Simpson WT
    Br Med J; 1976 Jul; 2(6028):137-9. PubMed ID: 776350
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Use of propranolol in the treatment of idiopathic orthostatic hypotension.
    Chobanian AV; Volicer L; Liang CS; Kershaw G; Tifft C
    Trans Assoc Am Physicians; 1977; 90():324-34. PubMed ID: 611664
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A multicenter double-blind study of the efficacy and safety of once and twice daily dilevalol compared to propranolol.
    Schoenberger JA; Wallin JD; Gorwit JI; Davidov ME; Michelson EL; Poland MP; Frishman WH
    Am J Hypertens; 1989 Nov; 2(11 Pt 1):840-6. PubMed ID: 2686711
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Acebutolol in essential hypertension: results of two multicenter studies against placebo and propranolol.
    Davidov M
    Am Heart J; 1985 May; 109(5 Pt 2):1158-67. PubMed ID: 2859780
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Enalapril in essential hypertension.
    Herrera-Acosta J; Pérez-Grovas H; Fernández M; Arriaga J
    Drugs; 1985; 30 Suppl 1():35-46. PubMed ID: 2994986
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Evaluation by practicing physicians of the antihypertensive efficacy of debrisoquin, methyldopa and propranolol].
    Avigdor L; Waeber B; Brunner HR
    Schweiz Med Wochenschr; 1983 Mar; 113(9):331-8. PubMed ID: 6342133
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.